Xilio Therapeutics, Inc. announced a private placement of 1,953,125 common shares at a price of $0.64 per share for the gross proceeds of $1,250,000 and prefunded warrants at a price of $0.6399 per prefunded warrant for the total gross proceeds of $11,300,000 on March 28, 2024. The private placement is expected to close on April 2, 2024, subject to the satisfaction of customary closing conditions.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | -1.83% | -1.82% | +96.36% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
65.7 USD | +0.44% | -1.69% | 81.58B | ||
1.07 USD | -1.83% | -1.82% | 40.23M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+96.36% | 40.23M | |
+1.54% | 42.75B | |
+47.70% | 41.61B | |
+11.75% | 41.34B | |
-8.83% | 26.59B | |
+6.41% | 25.49B | |
-23.28% | 18.12B | |
+29.92% | 12.24B | |
-2.58% | 11.76B | |
+8.17% | 11B |
- Stock Market
- Equities
- XLO Stock
- News Xilio Therapeutics, Inc.
- Xilio Therapeutics, Inc. announced that it expects to receive $11.3 million in funding